Trial Profile
An Observational study to evaluate the association of P2Y12-I (prasugrel and ticagrelor) loading dose with time in patients with ST segment Myocardial Infarction
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Apr 2020
Price :
$35
*
At a glance
- Drugs Prasugrel (Primary) ; Ticagrelor (Primary)
- Indications Myocardial infarction
- Focus Therapeutic Use
- 04 Jul 2017 New trial record